Sera Prognostics Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$2.02

+0.08 (+4.12%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,577.7% upside

Low Target $29.33

Average Target $33.89

High Target $54.04

Current Price $2.02

Current
$2.02

Target
$33.89

$29.33 $33.89 avg $54.04

Scenario Analysis

Bear Case

$29.33

1,352.0%

Low target

Base Case

$33.89

+1,577.7%

Avg target

Bull Case

$54.04

+2,575.2%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.85

-47.5% from high

52-Week Low

$1.56

+29.5% from low

Target vs 52W High

$33.89

+780.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%